Mecaton (Diosmin, Hesperidin)

Diosmin and hesperidin act on the vascular endothelium to strengthen venous walls, lower capillary permeability, and suppress inflammatory mediators. Their antioxidant activity protects vessels, enhances lymphatic drainage, and supports microcirculatory flow, addressing the underlying mechanisms of chronic venous disease.

The appropriate dose of Mecaton is determined by the prescribing healthcare professional based on the individual’s condition, severity, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Mecaton in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To order Mecaton, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Mecaton offers a flavonoid‑based approach that targets venous tone and microcirculation, whereas other options may include compression therapy, surgical interventions, or synthetic drugs such as veno‑active agents. Mecaton is taken orally and is available OTC, making it a convenient adjunct or alternative for patients with mild to moderate disease.

Mecaton tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in bathrooms or other humid environments.

Mecaton is taken orally with a glass of water, preferably after a meal to reduce gastrointestinal discomfort. The exact timing and frequency are prescribed by the treating clinician.

Serious adverse reactions, although rare, include anaphylactic shock, severe liver injury, blood‑clotting disorders, and severe skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, jaundice, unusual bruising, or widespread rash.

Mecaton should be avoided in individuals with known hypersensitivity to diosmin, hesperidin, or any excipients in the tablet. Patients with active bleeding disorders, uncontrolled hypertension, or those taking strong anticoagulants without medical supervision should consult a healthcare professional before use.